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Abstract
Purpose High protein weight loss diets are effective in aiding body weight management. However, high protein and low 
carbohydrate intakes can alter colonic fermentation profiles in humans and may impact on colonic health. This study aims 
to identify the most important dietary contributors to colonic fermentation during diet-controlled weight loss.
Methods Overweight or obese male volunteers (n = 18) consumed a body weight maintenance diet (fed at 1.5× basic 
metabolic rate, BMR) followed by three weight loss diets (fed at 1× BMR) for 10 days each in a cross-over design. Weight 
loss diets were designed as normal protein (NPWL, 15% of energy from protein, 55% from carbohydrate), normal protein 
enriched with free amino acids and moderate amounts of carbohydrate (NPAAWL, 15% of energy from protein, 15% from 
free AA, 40% from carbohydrate) or high protein containing moderate amounts of carbohydrate (HPWL, 30% of energy 
from protein, 40% from carbohydrate). Faecal samples collected at the end of each diet period were profiled for dietary 
metabolites using LC–MS/MS.
Results This study shows that the NPWL diet only induced very minor changes in the faecal metabolome, whereas NPAAWL 
and HPWL diets decreased carbohydrate-related metabolites (butyrate, ferulic acid) and increased protein-related metabolites. 
Most faecal metabolites were correlated with dietary carbohydrate and not protein intake.
Conclusion This study demonstrates that dietary carbohydrate is the main driver of colonic fermentation in humans and 
that a balance between dietary carbohydrate and protein should be maintained when designing safe, effective and healthy 
weight loss diets.
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Introduction
The balance of macronutrients in the human diet has long 
been recognised as being centrally important for maintain-
ing optimal health. Dietary carbohydrate intake forms the 
basis of our energy supply, whereas dietary protein pro-
vides the body with amino acids to maintain continuous 
protein turnover. Nonetheless, in settings of overconsump-
tion, dietary carbohydrate and especially added sugars and 
easily digestible polysaccharides have come under scrutiny 
in terms of easily accessible energy [1]. In contrast, non-
digestible forms of carbohydrate including resistant starches 
and non-starch polysaccharides are recognised as beneficial 
to human health via serving as substrates for fermentation 
by the microbiota resident in the human large intestine [2]. 
Health-promoting effects of dietary fibre (recommendation 
is currently at 30 g/day, [1]) are linked to the release of ben-
eficial fermentation products such as the short chain fatty 
acids (SCFA), propionate, acetate and butyrate. Butyrate acts 
as an energy source for colonic epithelium and is actively 
involved in maintaining normal colonocyte turnover and 
possesses anti-carcinogenic and anti-inflammatory poten-
tial [3]. Microbial fibre fermentation also releases numerous 
phenolic compounds into the colonic environment many of 
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which possess anti-oxidant and anti-inflammatory proper-
ties [4, 5]. Amongst these, ferulic acid as well as ferulic 
acid dimers and other metabolites are released in the colon 
following wheat-bran-enriched diets and are also absorbed 
into systemic circulation [6].
The role of dietary protein in colonic fermentation is 
less well understood. Older literature suggests that approxi-
mately 10% of dietary protein escapes digestion in the small 
intestine and acts as substrate for microbial breakdown into 
amino acids and possible fermentation to short chain fatty 
acids, branched chain fatty acids and ammonia in the human 
large intestine (for reviews see [7, 8]). Furthermore, colonic 
microbial fermentation of aromatic amino acids results in 
phenylacetic acid, 4-hydroxyphenylacetic acid and indole-
3-acetic acid and additional catabolites [9]. Diets high in 
protein from red meat have been shown to promote colonic 
tumour development and endogenous formation of carci-
nogenic N-nitroso compounds [10–12], which led to the 
recent classifications of processed and red meat as human 
carcinogen and probable human carcinogen, respectively, by 
the International Agency for the Research on Cancer [13]. 
Nevertheless, high protein diets are very successful in aid-
ing appetite control during weight loss in obese subjects 
[14, 15]. Consuming such weight loss diets with increased 
protein intake (mixed from meat, dairy and plant sources) 
and very low carbohydrate intake (including low dietary 
fibre) led to increased faecal protein fermentation products 
(including branched chain fatty acids, phenylacetic acid) 
as well as decreased fibre fermentation products (butyrate, 
ferulic acid) [16, 17]. It is not yet clear if increased protein 
and meat intake alone or in combination with decreased car-
bohydrate intake drives these shifts in colonic fermentation.
This study therefore aims to disentangle the potential 
effects of weight loss, dietary protein/meat and dietary car-
bohydrate on altering colonic fermentation by comparing 
three weight loss diets with varying protein and carbohy-
drate intakes. We designed diets to be body weight main-
tenance (M), normal protein weight loss (NPWL), normal 
protein weight loss enriched with free amino acids and con-
taining moderate amounts of carbohydrate (NPAAWL) and 
high protein weight loss containing moderate amounts of 
carbohydrate (HPWL). We collected faecal samples at the 
end of each diet period and profiled the faecal metabolome.
Subjects and methods
Subject characteristics
Overweight or obese healthy, male subjects with a 
BMI > 27 kg/m2, stable body weight (< 2 kg change in the 
past 3 months) and fasted blood glucose < 6 mmol/L were 
recruited into the study. Health status was confirmed by the 
subject’s General Practitioner and medical exclusion crite-
ria were: Diabetes, Kidney disease, Hepatic disease, Gout, 
Food allergy, Psychiatric disorders, Severe gastrointestinal 
disorders, Thromboembolic or Coagulation disease, Alco-
hol or Substance abuse, Eating disorders and Unregulated 
thyroid disease. The average baseline characteristics of all 
18 subjects were: age 49 ± 12 years (range 21–70), BMI 
36.6 ± 5.8 (range 26.5–51.7) and basic metabolic rate (BMR) 
9.0 ± 1.6 MJ/day (range 6.7–12.7). BMR was measured in 
each fasted volunteer and used to calculate the individual 
energy requirements. The study is focussed on men to mini-
mize variability as the number of participants was restricted 
by the complexity of the dietary design. Further details on 
the study volunteers and study design can be found in [18]. 
Medication exclusion criteria were: Orlistat, Rimonabant, 
Sibutramine, Oral antidiabetics including insulin, Digoxin, 
Anti-arrhythmics, Antidepressants, Anticoagulants and no 
antibiotics or drugs known to influence the faecal micro-
biota were taken immediately prior to or during the course 
of the study. The drugs reported by at least one subject on 
the study include: Amlodipine, Aspirin, Atenolol, Beco-
tide (inhalers), Bendroflumethiazide, Diclofenac, Diclofex, 
Enalipril, Felodipine, Ibuprofen, Liptor, Statin, Tamsulosin 
hydrochloride, Thyroxine, Tramadol, Trazodone, Valstatin 
and Ventolin (inhalers). Ethical approval was granted by 
the North of Scotland Research Ethics Committee and all 
subjects provided informed signed consent. All volunteers 
were asked not to change their lifestyle for the duration of 
the study and there were no drop-outs during the study.
Dietary intervention
There were four periods of dietary intervention, with all food 
supplied in cooked (breakfast) or ready-to-eat form (lunch 
and dinner). All food was prepared in-house and weighed 
by the kitchen research staff at the Human Nutrition Unit 
(HNU). Any leftover food that was not consumed by study 
subjects was collected and weighed to the nearest 0.1 g. All 
subjects (n = 18) first received a body weight maintenance 
diet (M, fed to 1.5× Basic Metabolic Rate, BMR) for 1 week 
before being randomised for consumption of three weight 
loss diets for 10 days each in a cross-over design. The weight 
loss diets were: a normal protein weight loss diet (NPWL, 
15% of energy from protein, 55% from carbohydrate), a nor-
mal protein weight loss diet enriched with free amino acids 
and moderate amounts of carbohydrate (NPAAWL, 15% of 
energy from protein, 15% from free AA, 40% from carbohy-
drate) or a high protein weight loss diet containing moder-
ate amounts of carbohydrate (HPWL, 30% of energy from 
protein, 40% from carbohydrate). The free amino acid profile 
of the NPAA diet matched that of beef and chicken [18]. All 
weight loss diets were fed at 1× BMR as three meals per 
day and prepared on a 5 days rotation menu. All subjects 
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consumed all three weight loss diets in a random order for 
10 days. No washout period was observed between the dif-
ferent diets as the faecal microbiome and metabolome have 
been shown to adapt to dietary changes within 1–2 days [19].
Analysis of dietary intakes
Using the HNU kitchen record and the subjects’ food dia-
ries, daily nutrient intakes for each subject were determined 
by trained staff using the WinDiets Nutritional Analysis 
Software Suite version 1.0 (The Robert Gordon University, 
Aberdeen, UK), a computerised version of McCance and 
Widdowson’s the composition of foods [20]. These individ-
ual daily intakes of macronutrients (carbohydrate, fat and 
protein), dietary fibre, non-starch polysaccharides, sugar, 
starch and total energy were then collated for analysis of sta-
tistical comparisons between the various diets (summarised 
in Table 1). For more detailed analysis of nutrient intake, 
exact food and nutrient intakes 4 days prior to each faecal 
sample collection were analysed and averages of 4 days were 
then correlated with faecal metabolites. Specific intakes 
of individual food items (e.g. meats) were extracted from 
the recipe sheets and the protein content of meat products 
was estimated as 25% of meat weight, based on a weighted 
average of the ingredients from the McCance and Widdow-
son’s food composition tables for cooked products [20]. 
The food group of red meat contained fresh and processed 
products of beef (steak, mince, topside, rump steak, burg-
ers, sausages) and pork (roast, fillet, loin chops, sausages, 
ham, bacon). White meat and fish included chicken (breast, 
Table 1  Average nutrient and 
food intakes of 18 volunteers on 
each study diet
Dietary components are given as mean intake over 4 days prior to faecal collection and average of all vol-
unteers (n = 18) on each diet ± SD
1 All nutrient intakes were calculated individually using WinDiets software
2 Total protein includes addition of free amino acids (60 g/day) for the normal protein + amino acid weight 
loss diet (NPAAWL) to match total protein content of high protein weight loss diet (HPWL)
3 The protein content of meat products was estimated as 25% of meat weight
4 Specific intakes of individual foods (all meat, red meat, white meat and fish, processed meat) were 
extracted from the recipe sheets
M NPWL NPAAWL HPWL
Energy1
 MJ/day 13.06 ± 1.44 9.02 ± 1.13 8.97 ± 1.07 8.82 ± 1.12
 Kcal/day 3118.65 ± 343.13 2154.27 ± 270.14 2143.47 ± 256.57 2105.96 ± 268.26
Fat1
 g/day 106.07 ± 11.58 73.23 ± 9.27 72.92 ± 8.90 71.62 ± 8.90
Total  carbohydrates1
 g/day 448.43 ± 49.77 308.61 ± 24.52 218.74 ± 25.76 219.37 ± 30.87
Starch1
 g/day 233.35 ± 26.29 167.18 ± 14.84 97.87 ± 15.84 104.60 ± 15.52
Sugar1
 g/day 214.70 ± 25.55 140.16 ± 10.20 119.65 ± 11.48 112.92 ± 14.57
Dietary  fibre1
 g/day 31.83 ± 3.42 28.50 ± 3.39 19.92 ± 2.68 18.13 ± 2.39
NSP1
 g/day 25.49 ± 3.77 26.63 ± 3.39 18.16 ± 2.34 18.29 ± 2.26
Total  protein1
 g/day 115.17 ± 12.58 79.54 ± 9.97 155.55 ± 18.042 153.06 ± 19.71
Protein from all  meat3
 g/day 30.35 ± 3.47 25.35 ± 3.03 33.52 ± 4.09 98.97 ± 13.72
All  meat4
 g/day 121.40 ± 13.86 101.41 ± 12.10 134.10 ± 16.34 395.86 ± 54.88
Red  meat4
 g/day 53.10 ± 8.52 50.32 ± 5.58 66.88 ± 12.81 158.38 ± 28.06
White meat and  fish4
 g/day 68.30 ± 11.78 51.09 ± 6.98 67.21 ± 8.31 237.48 ± 32.03
Processed  meat4
 g/day 27.29 ± 5.45 45.64 ± 7.27 61.44 ± 16.12 147.86 ± 27.99
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nuggets, sausages), turkey, tuna (canned in brine), prawns 
and haddock (in batter). The other main sources of protein 
were dairy products and eggs. Dietary fibre (expressed as 
non-starch polysaccharides) derived mainly from wholegrain 
bread and pasta, legumes and vegetables.
Faecal sample preparation
Freshly voided faecal samples provided by all volunteers 
were maintained at 4 °C for no longer than 5 h prior to pro-
cessing. Each sample was mixed in a stomacher (Seward; 
Bury St Edmunds, UK), centrifuged (50,000g; 12 °C; 2 h) 
and supernatant was collected as faecal water and stored 
at − 80 °C until analyses. All faecal water samples were 
defrosted on ice prior to chemical analysis.
Determination of short chain fatty acids 
and ammonia in faecal waters
Short chain fatty acids were determined using capillary gas 
chromatography [21]. The lower limit of reliable detection 
of each product was 0.2 mmol/L. Ammonia concentrations 
were analysed in 30-fold diluted faecal waters following 
reaction with sodium phenate and sodium hypochlorite by 
measuring absorbance of the indophenol product at 625 nm 
[22].
Analysis of apparent total N‑nitroso compounds 
(ATNC) in faecal waters
Faecal water samples were diluted 10-fold with distilled 
water and the content of N-nitroso compounds analysed by 
measuring the chemical release of nitric oxide detected on 
a thermal energy analyser. Concentrations were calculated 
by comparing the thermal response of a faecal water sam-
ple to the response of an N-nitrosodipropylamine standard 
(16.6 µg/mL) and values were expressed as apparent total 
N-nitroso compounds (ATNC) ng/mL faecal water sample.
Analysis of metabolites in faecal waters
Faecal water samples were thawed to 4 °C and 80 µl trans-
ferred to an Eppendorf tube. Internal standard 1 (13C-labelled 
benzoic acid; 80 µL), internal standard 2 (4,7,8-tri-MelQx; 
80 µL) and methanol (160 µL) were added. The samples 
were mixed, centrifuged (12,500×g; 5 min; 4 °C) and the 
supernatant analysed by LC–MS. Liquid chromatography 
separation of the metabolites produced was performed on 
an Agilent 1100 HPLC system (Agilent Technologies, Wok-
ingham, UK) using a Zorbax Eclipse 5 µm, 150 mm × 4 mm 
column (Agilent Technologies). Three different gradients 
were used to separate the different categories of metabo-
lites and the mobile phase solvents in each case were water 
containing 0.1% acetic acid and acetonitrile containing 0.1% 
acetic acid. In all cases the flow rate was 300 µL/min with an 
injection volume of 5 µL. The LC eluent was directed into, 
without splitting, an ABI 3200 triple quadrupole mass spec-
trometer (Applied Biosystems, Warrington, UK) fitted with 
a Turbo Ion Spray™ (TIS) source. For LC methods 1 and 
2, the mass spectrometer was run in negative ion mode with 
the following source settings: ion spray voltage − 4500 V, 
source temperature 400 °C, Gases 1 and 2 set at 15 and 40, 
respectively, and the Curtain Gas set to 10. For LC method 
3, the mass spectrometer was run in positive ion mode with 
the following source settings; ion spray voltage 5500, source 
temperature 400 °C, Gases 1 and 2 set at 14 and 40, respec-
tively, and the Curtain Gas set at 10. All the metabolites 
were quantified using multiple reaction monitoring. Stand-
ard solutions (10 ng/µL) for all analytes were prepared and 
pumped directly via a syringe pump. The ion transitions 
for each of the analytes were determined based upon their 
molecular ion and a strong fragment ion. For several catego-
ries of compounds, it was inevitable that their molecular ion 
and fragment ion would be the same, but this was overcome 
by their differing elution times. Their voltage parameters, 
declustering potential, collision energy and cell entrance/
exit potentials were optimised individually for each analyte.
Statistical analysis
Power calculations indicated that with 18 volunteers a treat-
ment effect of at least 20% could be detected with a power 
of 90% at the 5% significance level, assuming a within-vol-
unteer spread of 25%.
Data were analysed by analysis of variance with volunteer 
as a random effect and diet as a fixed effect. Initially, the 
effect of order and its interaction with diet were included in 
the analyses but these were found to be non-significant and 
were therefore omitted from subsequent analyses. When the 
effect of diet was significant (P < 0.05), means were com-
pared with post hoc t test. When the assumption of constant 
variance (and normality) was not met, data were log-trans-
formed before analysis. This was the case for the phytochem-
icals, lactate, lactate%, ATNC and other protein metabo-
lites. Zeros were replaced 0.5× the lowest non-zero value. 
For log-transformed data, the backtransformed (geometric) 
means and their corresponding 95% confidence intervals are 
presented. When more than 15% (more than ten samples out 
of 72 samples) of the samples were zero, non-parametric 
Friedman test was conducted instead. When the effect of 
diet was significant (P < 0.05), means were compared with 
Wilcoxon signed rank test. These data are presented as their 
mean and the number of zero samples out of the total sam-
ples tested. Linear relationships between variables were 
investigated with random effects linear regression, where 
volunteer was regarded as random. Log-transformation was 
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applied to the same set as variables as mentioned above and 
only metabolites for which less than 15% of the samples 
were zero were included. All data were analysed with Gen-
stat 17th Edn Release 17.1 (VSN International Ltd, Hemel 
Hempstead, Herts, UK). A P value < 0.05 was regarded as 
statistically significant.
Results
Nutrient and food intakes and weight loss on each 
study diet
The average scaled M diet for the volunteers was 13 MJ 
energy intake and contained normal proportions of macronu-
trients (Fig. 1). All weight loss diets were based on a reduced 
average energy intake (average 9 MJ/day). The NPWL diet 
comprised macronutrients in similar proportion to the M 
diet, but at decreased daily amounts. The NPAAWL diet 
was calculated to provide an increased protein intake in 
form of free amino acids which are expected to be rapidly 
absorbed in the small intestine. This increase was balanced 
by decreased carbohydrate intake from 448 to 309 g/day 
to make the weight loss diets iso-energetic (Table 1). The 
HPWL diet had a similarly decreased carbohydrate content 
compared to NPAAWL, but with all protein derived from 
normal food sources (meat, dairy and plant protein). Mean 
dietary fibre intake was 32 g/day (M), 29 g/day (NPWL), 
20 g/day (NPAAWL) and 18 g/day (HPWL). All subjects 
maintained their average baseline body weight (117.2 kg) on 
the M diet (116.4 kg) but significantly (P < 0.05) decreased 
the body weight on all weight loss diets (112.5 kg on NPWL, 
112.15 kg on NPAAWL and 112.36 kg on HPWL diets) 
[18]. Effect of diet on faecal SCFA.
The faecal short chain fatty acid butyrate was decreased 
(P < 0.028) in faeces of individuals on HPWL diet compared 
to M (19.16 versus 28.55 mM or 15.89 versus 19.43% of 
total SCFA, respectively; Table 2). Faecal propionate, iso-
butyrate, iso-valerate and valerate (as % of total SCFA) were 
increased (P < 0.043) in faeces of individuals consuming 
NPAAWL or HPWL diets when compared to M diet, but 
no such increase was observed when volunteers consumed 
the NPWL diet.
Effect of diet on phenolic compounds in faecal 
waters
Among the benzoic acid derivatives, several compounds 
were decreased in faeces of subjects consuming HPWL 
or NPAAWL diets compared to M (salicylic acid, gentisic 
acid, 2,6-dihydroxybenzoic acid, 3,5-dihydroxybenzoic acid, 
all P < 0.043), whereas others increased on the WL diets 
compared to M (protocatechuic acid, m-anisic acid, gal-
lic acid, vanillic acid, syringic acid, all P < 0.027). Several 
benzaldehydes also increased on WL diets (p-hydroxyben-
zaldehyde, protocatachaldehyde, 3,4,5-trihydroxybenzalde-
hyde, syringin, all P < 0.034), whereas most acetophenones 
decreased on the HPWL diet (all P < 0.036, Table 3). Cin-
namic acid and two cinnamic acid derivatives (ferulic and 
sinapic acid) as well as 4-hydroxy-3-methoxyphenylpropi-
onic acid were lower in faecal waters from subjects con-
suming WL diets compared with M (all P < 0.021, Table 4). 
On the other hand 4-hydroxymandelic acid, 3,4-dihydrox-
ymandelic acid and 4-hydroxyphenylpyruvic acid were 
increased on one or more of the WL diets compared to M 
(all P < 0.047). Faecal phenylacetic acids and most other 
metabolites were not significantly altered as a result of diet 
(Online Resource 1 and 2). Phenol was below the limit of 
detection in 69 of 72 faecal water samples tested. Several 
faecal metabolites were detected at very low concentrations 
and were absent in faecal samples of some volunteers, indi-
cating inter-individual variation in colonic substrate metabo-
lism [23].
Effect of diet on indoles, heterocyclic amines 
and apparent N‑nitroso compounds (ATNC)
Only minor changes were observed in indoles in fae-
cal waters (Table 4), whereas heterocyclic amines were 
increased on the HPWL diet compared to M (all P < 0.006), 
and several of these were also increased on either the 
Fig. 1  Diet composition summarised for the four study diets. Dietary 
components are given as percentage of total energy intake over 4 days 
prior to faecal collection and average of all 18 volunteers on each 
diet. CHO carbohydrate
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NPWL or the NPAAWL diet (P < 0.045). Faecal ATNC 
were also affected by diet (P = 0.001), with concentrations 
in faeces increased by all three weight loss diets compared 
to M (P < 0.031). ATNC in faeces of individuals con-
suming NPWL diet were lower compared to HPWL diets 
(P = 0.038).
Direct interactions between dietary components 
and faecal metabolites
As expected from the experimental design, dietary intakes 
of carbohydrates (total carbohydrate, starch, sugar, dietary 
fibre, non-starch polysaccharides or NSP) were strongly 
interrelated, as were dietary protein intakes (total protein, 
protein from red meat, protein from white meat, protein 
from all meat). Furthermore, faecal SCFA were positively 
associated with ferulic acid (r = 0.39, P < 0.001 where r is 
simple correlation coefficient and the P value is from ran-
dom effects regression) and negatively associated with faecal 
pH (r = − 0.56, P < 0.001), whereas faecal branched chain 
fatty acids (BCFA) were associated with phenylacetic acid 
(r = 0.86, P < 0.001), p-cresol (r = 0.83, P < 0.001), ammonia 
(r = 0.52, P < 0.001) and ATNC (r = 0.42, P < 0.001).
Principal component analysis (PCA) was used to further 
explore the diet-associated pattern of the faecal metabolome 
in volunteer samples (Fig. 2). Samples from volunteers on 
M diet were separated from those on HPWL diet, whereas 
samples from intermediate diets (NPWL, NPAAWL) were 
more dispersed. Samples from volunteers on M diet clus-
tered around dietary carbohydrate intake and carbohy-
drate-related fermentation products (ferulic acid as well as 
butyrate, acetate and total SCFA). Samples from volunteers 
consuming HPWL diet clustered around dietary protein and 
meat intake as well as some products of amino acid fermen-
tation (phenylacetic acid, indole-3-acetic acid, p-cresol) and 
meat-derived carcinogens (heterocyclic amines and ATNC).
Interactions between dietary components and faecal 
metabolites were also explored by correlation analysis 
(Fig. 3). Dietary carbohydrate appeared the main driver of 
colonic fermentation as most faecal metabolites were signifi-
cantly associated with carbohydrate intakes including total 
carbohydrate, starch, sugar, dietary fibre and NSP (28/60), 
some were associated with both carbohydrate and protein 
intakes (10/60) and only one metabolite (phenylpropionic 
acid) was solely associated with meat protein intake, but 
not with total protein intake. All carbohydrate components 
were positively associated with many of the carbohydrate-
related faecal metabolites including acetate, butyrate, total 
SCFA, salicylic acid, gentisic acid, 2,6-dihydroxybenzoic 
acid, 3,5-dihydroxybenzoic acid, ferulic acid, sinapic acid 
Table 2  Faecal pH and short 
chain fatty acids in faecal waters
Values are presented as means of 18 volunteers
1 Analysed by ANOVA with volunteer as random effect and diet as fixed effect. SED is standard error of 
the difference for comparing diet means. When the effect of diet was significant (P < 0.05), means were 
compared with post hoc t test. Means not sharing a superscript (a,b,c)  are significantly (P < 0.05) different
2 Data were log-transformed before analysis. Presented are backtransformed means and corresponding 95% 
confidence intervals
mmol/L MTD NPWL NPAAWL HPWL SED1 P  diet1
pH 6.69a 6.54a,b 6.43b 6.75a 0.12 0.043
Total SCFA 140.44 125.87 120.47 112.53 12.29 0.15
Acetate 77.03 68.09 64.88 61.11 6.77 0.12
Propionate 24.58 22.57 23.00 21.80 2.25 0.66
Butyrate 28.55a 25.72a,b 22.06a,b 19.16b 3.29 0.034
Isobutyrate 2.60 2.57 2.72 2.90 0.32 0.71
Isovalerate 2.20 2.26 2.49 2.69 0.31 0.39
Total BCFA 4.80 4.83 5.21 5.59 0.63 0.55
Valerate 3.46 3.11 3.45 3.41 0.37 0.74
Lactate 1.76 (1.36; 2.28) 1.49 (1.15;1.92) 1.61 (1.24;2.08) 1.43 (1.11; 1.85) na 0.392
% of total SCFA
Acetate 55.75 55.23 53.63 54.90 1.30 0.420
Propionate 17.21a 17.89a,b 19.17b,c 19.72c 0.72 0.004
Butyrate 19.43a 19.06a 18.19a 15.89b 1.01 0.005
Isobutyrate 1.89a 2.12a,b 2.35b,c 2.59c 0.21 0.015
Isovalerate 1.62a 1.90a,b 2.17b,c 2.39c 0.23 0.009
Total BCFA 3.51a 4.02a,b 4.52b,c 4.98c 0.44 0.011
Valerate 2.50a 2.49a 2.89b 2.94b 0.19 0.028
Lactate 1.31 (0.95; 1.82) 1.24 (0.89;1.72) 1.38 (1.00;1.92) 1.39 (1.01; 1.93) na 0.872
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and 4-hydroxy-3-methoxyphenylproprionic acid. Carbo-
hydrate intakes were also negatively associated with some 
benzoic acids (protocatechuic acid, gallic acid, vanillic acid) 
as well as some metabolites related to colonic amino acid 
fermentation (phenylacetic acid, p-cresol) and meat intake 
(heterocyclic amines, ATNC).
Dietary total protein and meat protein were negatively 
associated with faecal concentrations of 3,5-dihydroxy-
benzoic acid, ferulic acid and 4-hydroxy-3-methoxyphe-
nylproprionic acid. Furthermore, dietary meat protein was 
negatively associated with butyrate, salicylic acid, 2,6-dih-
droxybenzoic acid, sinapic acid and phenylpropionic acid. 
None of the protein intakes was associated with any amino 
acid-derived fermentation products (BCFA, phenylacetic acid, 
4-hydroxyphenylacetic acid, indole-3-acetic acid). Strong 
positive correlations were found between 2-amino-1-methyl-
6-phenylimiazo[4,5-b]pyridine and both dietary total protein 
and meat protein and between ATNC and dietary meat protein.
Discussion
Diet is widely recognised as main driver of colonic fermen-
tation (microbial metabolome), mainly through providing 
fermentable substrate rather than altering bacterial commu-
nity structure [24]. The current study aims to identify the 
most important dietary contributors to colonic fermentation 
in subjects consuming controlled weight loss diets that differ 
Table 3  Concentrations of benzoic acids, benzaldehydes, benzenes and acetophenones in faecal waters
1 Analysed by ANOVA with volunteer as random effect and diet as fixed effect. When the effect of diet was significant (P < 0.05), means were 
compared with post hoc t test. Means not sharing a superscript (a,b,c)  are significantly (P < 0.05) different. Data were log-transformed before 
analysis. Presented are backtransformed means (based on 18 volunteers) and corresponding 95% confidence intervals
2 Analysed by Friedman non-parametric test. When the effect of diet was significant (P < 0.05), means were compared with Wilcoxon signed rank 
test. Means not sharing a superscript (a, b, c) are significantly (P < 0.05) different. Presented are the means and the number of samples that were 
zero, out of 18 samples per diet
Name M NPWL NPAAWL HPWL P  diet1
Benzoic acids (ng/mL)
Salicylic acid 20.94a (15.17; 28.91) 13.79b (9.99; 19.03) 13.63b (9.87; 18.81) 11.00b (7.97; 15.19) 0.002
Gentisic acid 183.11a (108.80; 308.18) 148.01a,b (97.94; 249.11) 92.69b (55.08; 156.01) 90.16b (53.57; 151.74) 0.018
2,6-Dihydroxybenzoic acid 6.89a (4.33; 10.94) 3.40b (2.14; 5.40) 2.88b,c (1.81; 4.57) 2.11c (1.33; 3.35) 0.000
Protocatechuic acid 42.74a (30.75; 59.40) 122.65b (88.24; 170.48) 146.82b (105.63; 204.07) 106.08b (76.32; 147.45) 0.000
3,5-Dihydroxybenzoic acid 221.51a (174.73; 280.83) 220.42a (173.86; 279.44) 135.57b (106.94; 171.88) 148.02b (116.76; 187.65) 0.000
o-Anisic acid 11.30 (8/18) 30.78 (5/18) 33.22 (6/18) 28.51 (7/18) 0.0842
m-Anisic acid 0.96a (13/18) 3.47b (7/18) 3.89b (5/18) 3.14b (6/18) 0.0072
Gallic acid 12.05a (7.89; 18.41) 36.34b (23.79; 55.52) 36.18b (23.68; 55.27) 31.81b (20.82; 48.60) 0.000
Vanillic acid 45.29a (31.39; 65.35) 100.73b (69.81; 145.34) 118.93b (82.42; 171.60) 91.24b (63.24; 131.65) 0.000
Syringic acid 22.96a (14.11; 37.36) 59.81b (36.76; 97.31) 42.50b,c (26.12; 69.15) 34.43a,c (21.16; 56.02) 0.002
3,4-Dimethoxybenzoic acid 32.29 (13/18) 97.97 (12/18) 99.18 (10/18) 88.26 (9/18) 0.0992
Benzaldehydes (ng/mL)
p-Hydroxybenzaldehyde 71.38 a(50.35; 101.20) 86.96a,b (61.34; 123.29) 107.75 b (76.00; 152.77) 122.22b (86.21; 173.28) 0.017
Protocatachaldehyde 8.30a (6.44; 10.70) 12.59b (9.77; 16.23) 16.80c (13.03; 21.65) 15.81b,c (12.27; 20.38) 0.000
3,4,5-Trihydroxybenzal-
dehyde
2.18a (12/18) 16.66b (1/18) 15.29b (2/18) 15.77b (2/18) 0.0002
Syringin 4.47a (3.13; 6.38) 8.89b (6.23; 12.70) 6.75b (4.73; 9.65) 6.58b (4.60; 9.39) 0.004
Benzenes (ng/mL)
Catechol 63.60a (47.52; 85.12) 94.84b (70.68; 126.93) 86.01b,c (64.23; 115.12) 68.12a,c (50.90; 91.17) 0.025
Resorcinol 10.66 (9/18) 10.64 (13/18) 4.60 (14/18) 4.58 (13/18) 0.0772
Acetophenones (ng/mL)
4-Hydroxyacetophenone 1.68a (6/18) 0.64b (12/18) 1.26a,b (7/18) 0.80b (10/18) 0.0342
4-Hydroxy-3-methoxyace-
tophenone
2.42a (8/18) 0.95a,b (12/18) 0.62b (13/18) 0.40b (15/18) 0.0242
4-Hydroxy-3,5-dimethoxy-
acetophenone
10.44a (4/18) 7.37a (6/18) 5.78a,b (8/18) 3.00b (12/18) 0.0142
3,4,5-Trimethoxyacetophe-
none
348.77 (237.46; 512.27) 546.74 (372.24; 803.03) 353.65 (240.78; 519.43) 466.94 (317.91; 685.83) 0.060
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in carbohydrate, fibre and protein content. The study is lim-
ited to a small number (n = 18) of obese or overweight male 
subjects, but at the same time this design facilitates very 
rigorous control of dietary intakes over an extended period 
(37 days in total). Diets were designed to contain dietary 
fibre at either the current UK dietary recommendations of 
30 g/day (for M and NPWL diets) or the UK average intake 
of 18 g/day (for NPAAWL and HPWL diets) [1]. At the 
same time, dietary total protein varied substantially (115, 
79, 156 and 153 g/day for M, NPWL, NPAAWL and HPWL 
diets, respectively). All three weight loss diets resulted in 
similar weight loss.
The most pronounced dietary change occurred between 
the balanced M diet and the HPWL diet and this change 
induced a substantial shift in faecal metabolite profiles. 
Most importantly, the main fibre-derived beneficial metab-
olites were decreased in HPWL diets including butyrate, 
ferulic acid, sinapic acid and 4-hydroxy–3-methoxyphe-
nylpropionic acid as well as salicylic and gentisic acid. 
These changes are more pronounced than reported in a 
similar study comparing M and HPWL diets (only butyrate 
was decreased when NSP fibre intake was decreased from 
22 to 13 g/day, [17]). These compounds are believed to 
exert potent antioxidant effects and other beneficial health 
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Fig. 2  PCA plot for all metabolites for which ANOVA showed a 
significant effect of diet, or for which the random effects regression 
showed a significant relationship between dietary components and 
metabolic products. Also included are four representative dietary 
intakes. All data were log-transformed except for dietary intakes, 
SCFA concentrations and pH and were centred within volunteer. 
Results are presented for samples from volunteers on M diet (circle); 
NPWL diet (triangle); NPAAWL diet (plus) and HPWL diet (square). 
Major dietary intakes are depicted as D1 (carbohydrate), D2 (dietary 
fibre), D3 (protein) and D4 (meat). Faecal metabolites are depicted as 
M1–M39, full chemical names are displayed in Fig. 3
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Fig. 3  Associations between 
dietary intakes and fae-
cal metabolites. Grey circle 
significant (P < 0.05) posi-
tive relationship, white circle 
significant (P < 0.05) negative 
relationship, bigger circle 
means more significant. Blank 
entries indicate non-significant 
association. Based on random 
effects regression of metabolite 
(dependent variable) on dietary 
component (explanatory vari-
able), with volunteer as random 
effect. All metabolites were 
log-transformed before analysis 
with the exception of pH, 
ammonia and the SCFA con-
centrations (except for lactate, 
which was log-transformed). 
Only metabolites for which no 
more than ten samples (out of a 
total of 72) were zero or at the 
limit of detection were analysed
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effects, and their increased faecal concentrations might 
reflect intake of fruit and vegetables [25]. At the same 
time, meat-related potential carcinogens including sev-
eral HCA and ATNC were increased in faeces of subjects 
consuming HPWL diets. However, this increase was less 
pronounced than reported previously, possibly due to 
the relatively high amount of fibre present in HPWL diet 
compared to the published study [17]. Similarly, branched 
chain fatty acids, p-cresol and 4-hydroxyphenylpyruvic 
acid increased in faeces of subjects on HPWL diets as did 
potential amino-acid metabolites p-hydroxybenzaldehyde 
and protocatachaldehyde. Other metabolites linked to the 
fermentation of aromatic amino acids [9] such as indoles, 
phenylacetic acid and 4-hydroxyphenylacetic acid as well 
as ammonia remained unchanged by diet. Similarly, Rus-
sell et al. [17] found BCFA and phenylacetic acid increas-
ing, whereas other metabolites were unchanged. These 
findings point towards potentially increased colonic amino 
acid fermentation during HPWL diet period, although not 
all relevant metabolites respond.
In comparison, the shift from M to NPAAWL diet also 
induced significant changes in the faecal metabolome. With 
the exception of butyrate, all other changes were compa-
rable to the ones induced by HPWL diet. This finding is 
important, especially when meat-derived carcinogenic 
compounds are concerned. Despite a 2.9-fold lower meat 
intake on the NPAAWL diet compared to HPWL, the faecal 
concentrations of heterocyclic amines and ATNC were not 
significantly different. We found that consuming a HPWL 
diet resulted in a 1.9-fold increase in ATNC compared to M 
diet, while consuming NPAAWL led to a 1.4-fold increase. 
Possibly, the amount of dietary fibre in both HPWL and 
NPAAWL diets (18 g/day) was sufficient to counteract an 
increase in colonic ATNC production observed previously 
(3.6-fold increase, [17]). Other factors such as cooking and 
preservation method as well as Vitamin C intake might have 
also influenced the faecal levels of meat-related carcinogens 
in the NPAAWL diet [12].
When subjects consumed a balanced NPWL diet, several 
differences in faecal metabolome were observed compared 
to M. Several phytochemical-derived metabolites (gallic 
acid, vanillic acid, syringic acid, syringin) were increased 
in NPWL diets. At the same time some meat-related carcino-
gens also increased which probably reflects the increase in 
processed meat on NPWL diets compared to M. However, 
many of these changes were less pronounced then in HPWL 
diet. Taken together, NPWL diet appears preferable among 
the three weight loss diets in terms of faecal metabolite pro-
files as several beneficial fermentation products (butyrate, 
ferulic acid, its metabolites 4-hydroxy-3-methoxyphenyl-
propionic acid as well as syringic acid) are higher com-
pared with the HPWL diet, while some meat-derived car-
cinogens (2-amino-1-methyl-6-phenylimiazo[4,5-b]pyridine, 
ATNC) are lower. At the same time, the extent of weight 
loss achieved by all three diet regimes was similar (average 
4.1 kg), although hunger scores were higher for subjects on 
NPWL diet [18].
Correlation analysis between dietary intakes and faecal 
metabolites clearly indicates that dietary carbohydrates and 
fibre drive the most significant changes in faecal metabolite 
profiles. The interactions with dietary protein appear sec-
ondary as most faecal metabolites which were associated 
with protein are also inversely correlated with carbohydrate 
intakes. This is in line with the notion that most fermentable 
protein in the colon derives from endogenous sources rather 
than dietary intake [8]. Dietary non-digestible carbohydrates 
are the primary substrate for microbial fermentation in the 
human colon and only once the carbohydrate sources are 
depleted will protein breakdown and amino acid fermen-
tation increase for certain microbial species. Consuming 
wheat-bran supplements as part of a normal diet not only 
increases the faecal and systemic level of ferulic acids and 
other beneficial carbohydrate related metabolites, but at 
the same time decreases amino acid fermentation products, 
although non-significantly [6]. Supplementing high-protein 
diets (meat, dairy or vegetable protein) with dietary fibre 
(type IV resistant starch or pectin) significantly shifts faecal 
fermentation towards increased SCFA and decreases amino 
acid fermentation [26, 27] and prevents red meat-induced 
pro-mutagenic lesions in rectal mucosa in humans [26]. It 
is therefore highly likely that delivery of larger amounts of 
dietary fibre in the diet could be used as a tool to prevent 
and offset the negative effect of increased protein consump-
tion in terms of protein fermentation products in the colonic 
environment. Future studies will corroborate these findings 
in wider populations and specific interventions will further 
affirm the causality of faecal metabolomics changes.
Conclusion
In the current study consumption of a balanced normal pro-
tein weight loss diet achieved weight loss without signifi-
cantly altering the faecal metabolite profile. Consumption 
of a high protein diet on the other hand shifted the faecal 
metabolome towards a more detrimental profile. Our find-
ings suggest that the decrease in carbohydrate and fibre con-
tent of high-protein weight loss diets contributes to these 
detrimental shifts and should be avoided when designing 
future weight loss diets.
Acknowledgements Authors would like to thank the staff of the human 
nutrition unit at the Rowett Institute for delivering the study and David 
Bremner for assisting with sample collection and preparation. This 
study was funded by the Rural and Environment Science and Analytical 
Services Division (RESAS) of the Scottish Government.
1158 European Journal of Nutrition (2019) 58:1147–1158
1 3
Author contributions AMJ and GEL planned and conducted the human 
intervention study; CF developed diets, carried out the dietary inter-
vention and analysed dietary intake data; SWG and WRR planned and 
oversaw faecal collection and metabolic analysis; SH, AJR and LS 
processed faecal samples and performed metabolites analysis; GH 
advised on data presentation and performed statistical analysis; SWG 
and WRR analysed results, interpreted data and contributed to the intel-
lectual content of the manuscript; SWG was primarily responsible for 
preparing the manuscript; all authors contributed to the manuscript and 
approved the final version.
Compliance with ethical standards 
Conflict of interest None of the authors have declared a conflict of in-
terest.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution 4.0 International License (http://creat iveco 
mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribu-
tion, and reproduction in any medium, provided you give appropriate 
credit to the original author(s) and the source, provide a link to the 
Creative Commons license, and indicate if changes were made.
References
 1. Scientific Advisory Committee on Nutrition UK (2015) Carbo-
hydrates and health. Public Health Engl (ISBN: 978 0 11 708284 
7). https ://www.gov.uk/gover nment /uploa ds/syste m/uploa ds/attac 
hment _data/file/44550 3/SACN_Carbo hydra tes_and_Healt h.pdf
 2. Flint HJ, Duncan SH, Scott KP, Louis P (2015) Links between 
diet, gut microbiota composition and gut metabolism. Proc Nutr 
Soc 74:13–22
 3. Canani RB, Di Costanzo M, Leone L, Pedata M, Meli R, 
Calignano A (2011) Potential beneficial effects of butyrate in 
intestinal and extraintestinal diseases. World J Gastroenterol 
17(12):1519–1528
 4. Russell WR, Drew JE, Scobbie L, Duthie GG (2006) Inhibition 
of cytokine-induced prostanoid biogenesis by phytochemicals in 
human colonic fibroblasts. BBA Mol Basis Dis 1762(1):124–130
 5. Russell WR, Scobbie L, Chesson A (2005) Structural modifi-
cation of phenylpropanoid-derived compounds and the effects 
on their participation in redox processes. Bioorgan Med Chem 
13(7):2537–2546
 6. Neacsu M, McMonagle J, Fletcher R, Hulshof T, Duncan SH, 
Scobbie L, Duncan GJ, Cantlay L, Horgan G, De Roos B, Duthie 
GG, Russell WR (2016) Availability and dose response of phyto-
phenols from a wheat bran-rich cereal product in healthy human 
volunteers. Mol Nutr Food Res 61(3):1600202
 7. Hamer HM, De Preter V, Windey K, Verbeke K (2012) Functional 
analysis of colonic bacterial metabolism: relevant to health? Am 
J Physiol Gastrointest Liver Physiol 302:G1–G9
 8. Scott KP, Gratz SW, Sheridan PO, Flint HJ, Duncan SH (2013) The 
influence of diet on the gut microbiota. Pharmacol Res 69:52–60
 9. Russell WR, Duncan SH, Scobbie L, Duncan G, Cantlay L, Cal-
der AG, Anderson SE, Flint HJ (2013) Major phenylpropanoid-
derived metabolites in the human gut can arise from microbial 
fermentation of protein. Mol Nutr Food Res 57:523–35
 10. Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, Kampman 
E, Norat T (2011) Red and processed meat and colorectal can-
cer incidence: meta-analysis of prospective studies. PLoS One 
6(6):e20456
 11. Bingham SA, Hughes R, Cross AJ (2002) Effect of white versus 
red meat on endogenous N-nitrosation in the human colon and 
further evidence of a dose response. J Nutr 132:S3522–S3525
 12. Holtrop G, Johnstone AM, Fyfe C, Gratz SW (2012) Diet com-
position is associated with endogenous formation of N-nitroso 
compounds in obese men. J Nutr 142(9):1652–1658
 13. Bouvard V, Loomis D, Guyton KZ, Grosse Y, Ghissassi FE, 
Benbrahim-Tallaa L, Guha N, Mattock H, Straif K (2015) Car-
cinogenicity of consumption of red and processed meat. Lancet 
Oncol 16:1599–1600
 14. Johnstone A (2012) Safety and efficacy of high-protein diets for 
weight loss. Proc Nutr Soc 71(2):339–349
 15. Bendtsen LQ, Lorenzen JK, Bendsen NT, Rasmussen C, Astrup 
A (2013) Effect of dairy proteins on appetite, energy expenditure, 
body weight, and composition: a review of the evidence from 
controlled clinical trials. Adv Nutr 4(4):418–438
 16. Duncan SH, Belenguer A, Holtrop G, Johnstone AM, Flint HJ, 
Lobley GE (2007) Reduced dietary intake of carbohydrates by 
obese subjects results in decreased concentrations of butyrate 
and butyrate-producing bacteria in feces. Appl Environ Microbiol 
73:1073–1078
 17. Russell WR, Gratz SW, Duncan SH, Holtrop G, Ince J, Scobbie L, 
Duncan G, Johnstone A, Lobley G, Wallace RJ, Duthie GG, Flint 
HJ (2011) High-protein, reduced-carbohydrate weight-loss diets 
promote metabolite profiles likely to be detrimental to colonic 
health. Am J Clin Nutr 93:1062–1072
 18. Lobley GE, Holtrop G, Horgan GW, Bremner DM, Fyfe C, John-
stone AM (2015) Responses in gut hormones and hunger to diets 
with either high protein or a mixture of protein plus free amino acids 
supplied under weight-loss conditions. Br J Nutr 113:1254–1270
 19. David LA, Maurice CF, Carmody RN, Gootenberg DB, But-
ton JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach 
MA, Biddinger SB, Dutton RJ, Turnbaugh PJ (2014) Diet rap-
idly and reproducibly alters the human gut microbiome. Nature 
505(7484):559–563
 20. FSA (2002) McCance and Widdowson’s the composition of food, 
Royal Society of Chemistry, Cambridge
 21. Richardson AJ, Calder AG, Stewart CS, Smith A (1989) Simulta-
neous determination of volatile and non-volatile acidic fermenta-
tion products of anaerobes by capillary gas-chromatography. Lett 
Appl Microbiol 9:5–8
 22. Whitehead R, Cooke GH, Chapman BT (1967) Problems associ-
ated with the continuous monitoring of ammoniacal nitrogen in 
river water. Automat Anal Chem 2:337–380
 23. Duncan SH, Russell WR, Quartieri A, Rossi M, Parkhill J, Walker 
AW, Flint HJ (2016) Wheat bran promotes enrichment within the 
human colonic microbiota of butyrate-producing bacteria that 
release ferulic acid. Environ Microbiol 18(7):2214–2225
 24. Wu GD, Compher C, Chen EZ, Smith SA, Shah RD, Bittinger 
K, Chehoud C, Albenberg LG, Nessel L, Gilroy E, Star J, Weljie 
AM, Flint HJ, Metz DC, Bennett MJ, Li H, Bushman FD, Lewis 
JD (2016) Comparative metabolomics in vegans and omnivores 
reveal constraints on diet-dependent gut microbiota metabolite 
production. Gut 65(1):63–72
 25. Russell WR, Duthie G (2011) Plant secondary metabolites and gut 
health: the case for phenolic acids. Proc Nutr Soc 70(3):389–396
 26. Le Leu R, Winter JM, Humphreys KJ, Young GP, Christophersen 
CT, Hu Y, Gratz SW, Miller RM, Topping DL, Bird AR, Con-
lon MA (2015) Butyrylated starch intake can prevent red meat 
induced O6-methyl-2-deoxyguanosine adducts in human rectal 
tissue: a randomised clinical trial. B J Nutr 114:220–230
 27. Adam CL, Gratz SW, Peinado DI, Thomson LM, Garden KE, 
Williams PA, Richardson AJ, Ross AW (2016) Effects of dietary 
fibre (pectin) and/or increased protein (casein or pea) on satiety, 
weight loss and caecal fermentation in high fat diet-induced obese 
rats. PLoS One 11(5):e0155871
